Humana Inc. (NYSE: HUM), a leading health and well-being company, reported a decrease in adjusted earnings for the second quarter of 2024
Earnings Summary: Highlights of Humana’s Q2 2024 report
Categories
Health Care
Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted basis, compared
Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3%
Earnings Summary: A snapshot of DexCom’s Q2 2024 financial results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) has reported an increase in revenue and adjusted earnings for the second quarter of 2024. The
Earnings Summary: Centene Corp’s Q2 2024 revenue and profit increase
Healthcare service provider Centene Corporation (NYSE: CNC) on Friday announced second-quarter 2024 results, reporting an increase in revenues and adjusted earnings. Total
BMY Earnings: Bristol-Myers Squibb reports higher Q2 revenue and profit
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported higher revenues and net profit for the second quarter of 2024. Net income
Trxade Health closes business combination with Scienture in $103Mln deal
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with New York-based
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase
Envoy Medical is well-positioned to gain market share in hearing implant space: CEO
Envoy Medical (NASDAQ: COCH) is a leader in hearing solutions, offering innovative hearing technologies and advanced hearing implants. Its fully implanted hearing
Earnings Summary: IQVIA reports higher revenue and adj. profit for Q2 2024
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
ISRG Earnings: Intuitive Surgical Q2 profit jumps on strong revenue growth
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2024, reporting higher revenues and adjusted
Abbott Laboratories (ABT) Q2 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today. Net sales increased 4% year-over-year to $10.4 billion. Net earnings decreased
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today. Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales
Infographic: How UnitedHealth Group (UNH) performed in Q2 2024
UnitedHealth Group (NYSE: UNH) reported second quarter 2024 earnings results today. Revenues increased to $98.9 billion from $92.9 billion a year ago.
Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024
Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth.
Johnson & Johnson to publish Q2 report next week. Here’s what to look for
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) has constantly strengthened its portfolio over the years by acquiring new businesses, investing in new
UNH Earnings Preview: What to expect when UnitedHealth reports Q2 results
Health insurer UnitedHealth Group (NYSE: UNH) stands out in the healthcare space for its unique business model covering a broad range of
Everything you need to know about OS Therapies’ upcoming IPO
There has been a strong uptick in IPO activity this year compared to 2023 when the market witnessed a slowdown. In the
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company
Alumis looks to raise $300 million in IPO. Here’s what you need to know
Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared to 2023.
WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment.